Organ-specific metastasis of breast cancer: molecular and cellular mechanisms underlying lung metastasis
- PMID: 29568985
- DOI: 10.1007/s13402-018-0376-6
Organ-specific metastasis of breast cancer: molecular and cellular mechanisms underlying lung metastasis
Abstract
Background: Breast cancer (BC) is the most common type of cancer in women and the second cause of cancer-related mortality world-wide. The majority of BC-related deaths is due to metastasis. Bone, lung, brain and liver are the primary target sites of BC metastasis. The clinical implications and mechanisms underlying bone metastasis have been reviewed before. Given the fact that BC lung metastasis (BCLM) usually produces symptoms only after the lungs have been vastly occupied with metastatic tumor masses, it is of paramount importance for diagnostic and prognostic, as well as therapeutic purposes to comprehend the molecular and cellular mechanisms underlying BCLM. Here, we review current insights into the organ-specificity of BC metastasis, including the role of cancer stem cells in triggering BC spread, the traveling of tumor cells in the blood stream and their migration across endothelial barriers, their adaptation to the lung microenvironment and the initiation of metastatic colonization within the lung.
Conclusions: Detailed understanding of the mechanisms underlying BCLM will shed a new light on the identification of novel molecular targets to impede daunting pulmonary metastases in patients with breast cancer.
Keywords: Breast cancer; Cancer stem cell; Epithelial-mesenchymal transition; Lung metastasis; Lung micro-environment; Pulmonary vasculature.
Similar articles
-
Effects of letrozole on breast cancer micro-metastatic tumor growth in bone and lung in mice inoculated with murine 4T1 cells.Clin Exp Metastasis. 2016 Jun;33(5):475-85. doi: 10.1007/s10585-016-9792-z. Epub 2016 May 21. Clin Exp Metastasis. 2016. PMID: 27209469
-
Organotropism of breast cancer metastasis.J Mammary Gland Biol Neoplasia. 2007 Sep;12(2-3):153-62. doi: 10.1007/s10911-007-9047-3. J Mammary Gland Biol Neoplasia. 2007. PMID: 17566854 Review.
-
Molecular Mechanisms of Breast Cancer Metastasis to the Lung: Clinical and Experimental Perspectives.Int J Mol Sci. 2019 May 8;20(9):2272. doi: 10.3390/ijms20092272. Int J Mol Sci. 2019. PMID: 31071959 Free PMC article. Review.
-
Organ-Specificity of Breast Cancer Metastasis.Int J Mol Sci. 2023 Oct 26;24(21):15625. doi: 10.3390/ijms242115625. Int J Mol Sci. 2023. PMID: 37958607 Free PMC article. Review.
-
Ras-proximate-1 (RAP1): a prognosis and therapeutic target in the metastatic spread of breast cancer.Clin Exp Metastasis. 2025 Apr 11;42(3):23. doi: 10.1007/s10585-025-10342-5. Clin Exp Metastasis. 2025. PMID: 40214810 Review.
Cited by
-
Macrophage-Secreted S100A4 Supports Breast Cancer Metastasis by Remodeling the Extracellular Matrix in the Premetastatic Niche.Biomed Res Int. 2022 Apr 20;2022:9895504. doi: 10.1155/2022/9895504. eCollection 2022. Biomed Res Int. 2022. PMID: 35496059 Free PMC article.
-
Systematic Pan-Cancer Population-Based Analysis Reveals the Incidence and Prognosis of Lung Metastases at Diagnosis.J Oncol. 2021 Jun 15;2021:9999968. doi: 10.1155/2021/9999968. eCollection 2021. J Oncol. 2021. PMID: 34221015 Free PMC article.
-
Thyroid Metastasis from Primary Breast Cancer.J Clin Med. 2023 Apr 4;12(7):2709. doi: 10.3390/jcm12072709. J Clin Med. 2023. PMID: 37048792 Free PMC article. Review.
-
Impact of the Cancer Cell Secretome in Driving Breast Cancer Progression.Cancers (Basel). 2023 May 8;15(9):2653. doi: 10.3390/cancers15092653. Cancers (Basel). 2023. PMID: 37174117 Free PMC article. Review.
-
Phototherapy using immunologically modified carbon nanotubes to potentiate checkpoint blockade for metastatic breast cancer.Nanomedicine. 2019 Jun;18:44-53. doi: 10.1016/j.nano.2019.02.009. Epub 2019 Mar 4. Nanomedicine. 2019. PMID: 30844573 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical